platinum has been researched along with Esophagitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kimbara, K; Kunitoh, H; Nagatomo, A; Okamoto, H; Watanabe, K | 1 |
1 other study(ies) available for platinum and Esophagitis
Article | Year |
---|---|
Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Radiotherapy Dosage; Survival Analysis | 1997 |